Real-time insights. Smarter decisions. Better trades.
🔍 Search Stocks 14 day Free Trial
CYCLOPHARM LIMITED (CYC)ASX AI Signals has generated 0 signals for CYC during the last 90 days, indicating low trading activity
CYC Share Price | |
| Current Price | $0.495 |
| 52 Week High | $1.230 |
| 52 Week Low: | $0.470 |
| Trading at (% of 52 Week High) | 40.24% |
Cyclopharm Limited (ASX: CYC) is a medical technology company specializing in the development and supply of diagnostic imaging products. The company produces Technegas, a device used in lung ventilation studies to assist in diagnosing respiratory conditions. Cyclopharm operates internationally, providing its technology and services to healthcare professionals.
The Health Care Equipment & Services sector on the ASX includes companies that produce medical devices, equipment, and supplies, as well as those providing healthcare-related services. This sector covers a wide range of products such as surgical instruments, diagnostic machines, and health monitoring devices. It also includes businesses involved in healthcare management, medical laboratories, and support services. These companies play a key role in supporting hospitals, clinics, and other healthcare providers to improve patient care. The sector is influenced by factors like technological advances, regulatory changes, and demand for healthcare services.
As the Australian market shows signs of recovery with a significant 101-point advance, optimism is building around the potential resolution of Middle East tensions and its positive impact on global indices. In this environment, growth companies with high insider ownership can be particularly appeali Australian shares have shown a positive shift following the successful meeting between Anthony Albanese and Donald Trump, which focused on critical minerals and the AUKUS partnership. As investors navigate these developments, attention turns to penny stocks, a term that may seem outdated but still h As the Australian market follows the global uptick, with ASX 200 futures indicating a positive start, investors are keenly observing opportunities that arise from this buoyant sentiment. Penny stocks, though an older term, still capture interest due to their potential for growth and value in smallerLatest CYCLOPHARM LIMITED(CYC) News
ASX Growth Stocks With High Insider Ownership In April 2026
Promising ASX Penny Stocks To Consider In October 2025
ASX Penny Stocks Spotlight: Alcidion Group And 2 Other Noteworthy Picks
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial • Cancel Anytime • Founders Price $15/month
Start My Free Trial